Canada-based Fullscript and smart ring maker ŌURA (San Francisco, CA) have announced a strategic partnership to bring Oura’s biometric insights directly into Fullscript’s clinical workflow. With the integration of Oura into the Fullscript platform, for the first time providers will be able to access wearable data, lab results and patient treatment history in one place, enabling a truly comprehensive, provider-facing view that enables the seamless delivery of whole person care.
“This partnership is a monumental step toward real-time, whole person care,” said Kyle Braatz, CEO and co-founder of Fullscript. “Oura’s continuous health signals are powerful on their own, but when paired with Fullscript’s clinical insights, lab data, and personalized protocols, they become transformative. Providers can now bring more context to treatment conversations and ongoing care management, allowing for more comprehensive care, all without leaving their existing workflow.”
“Continuous, longitudinal health signals, like those captured with Oura Ring, are most powerful when they’re connected to real clinical decision-making,” added Dr. Ricky Bloomfield, chief medical officer at Oura. “By integrating Oura insights into Fullscript, we’re giving providers a deeper view of how their patients are sleeping, recovering and responding to daily stressors, so they can spend less time stitching data together and more time delivering proactive, preventive care that benefits individuals, clinicians and health systems alike.”
More than 125,000 providers who use Fullscript will soon be able, for patients who opt in, to view patient Sleep, Readiness and Activity trend data from Oura alongside medical history and lab diagnostics. These biometric insights are intended to inform a clinician’s decision-making process and help guide care pathways.
For patients, this integration creates a more connected care experience. With their biometric trends, supplement protocols and lab results viewable by their provider within one system, patients benefit from a more unified, personalized treatment plan. This consolidation of data helps ensure consistency across care recommendations and strengthens patient engagement by reinforcing how daily habits connect to clinical outcomes.
“Patients don’t just want more data—they want providers who can translate that data into care that feels personal, timely, and relevant to their everyday lives,” said Joanna Strober, CEO and co-founder of Midi Health. “By bringing Oura’s continuous health signals into Fullscript’s clinical platform and into Midi’s workflows, we can give our patients more tailored treatment plans and more meaningful follow-up, while strengthening each of our platforms’ positions as leaders in a rapidly evolving, data-driven health care market.”
Providers on Fullscript will be able to consider Oura data across a range of scenarios:
- Low Readiness scores may prompt clinicians to have discussions around recovery strategies, modifications to training plans or stress management techniques.
- Improved sleep metrics may lead to decisions to taper interventions or reinforce healthy routines.
- Activity trends may guide the timing of lifestyle recommendations or lab follow ups.
The integration will begin rolling out in early 2026, giving Fullscript practitioners the ability to access and act on their patients’ Oura data from directly within the Fullscript platform. In early Q2, Oura Ring will be available for ordering directly through the Fullscript catalog, enabling clinicians to easily incorporate wearables into their care strategies.
For more information, visit https://fullscript.com or https://ouraring.com.
